However, in vitro data suggest that TNF‐α may exert a neuroprotective effect by stimulating neuronal cells to express bcl‐2,18 which may explain the elevated risk of developing AD in APOE‐ε4 carriers with decreased TNF‐α levels. This evidence concerns the gene TNF and Alzheimer disease.